Impact of Mindful Self-Compassion Therapy on Self Harm Behaviors, Emotional Regulation and Quality of Life Among Patients With Borderline Personality Disorder

ConditionsPsychological Distress Emotional Regulation Self Harm Quality of Life (QOL)Borderline Personality Disorder (BPD)

Trial statusRecruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age18+

SponsorFatima Jinnah Women University

About this trial

The primary purpose of the study is to investigate whether Mindful Self-Compassion (MSC) therapy can significantly reduce self-harm behaviors, improve emotional regulation, and enhance the quality of life in individuals diagnosed with Borderline Personality Disorder (BPD). The study aims to contribute to the existing literature by providing robust evidence on the efficacy of MSC therapy for BPD, which could inform clinical practices and improve treatment outcomes

Eligibility criteria

Qualifiers

1. First time diagnosed non-hospitalized patients of Borderline Personality Disorder.

Disqualifiers

Hospitalized patients of Borderline Personality

Patients with Borderline Personality having other chronic co-morbid diseases such as cancer, cognitive deficits, and other chronic psychological disorders.

Patients with Borderline Personality younger than 18 years of age

Trial design

Treatments tested in this trial

Mindful Self Compassion Therapy

Treatment groups

60 Participants

are divided into 2 treatment groups

Sponsors and collaborators

Fatima Jinnah Women University

Lead sponsor

Source ClinicalTrials.gov